Masatoshi Hirayama

发表

Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro

S. Senju, Y. Nishimura, H. Hamana, 2018, Oncoimmunology.

Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology

S. Senju, Y. Nishimura, Y. Tomita, 2016, PloS one.

Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia

Masatoshi Hirayama, H. Nakayama, M. Shinohara, 2017, Cancer medicine.

The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation

R. Murakami, Y. Kuwahara, M. Fukumoto, 2022, Laboratory Investigation.

Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.

S. Senju, Y. Nishimura, Hirotake Tsukamoto, 2017, Cancer research.

Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration

Yukio Fujiwara, Masatoshi Hirayama, H. Nakayama, 2022, Cancer Immunology, Immunotherapy.

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Nakamura, S. Senju, Y. Nishimura, 2013, Clinical Cancer Research.

Development of HLA-modified induced pluripotent stem cell-derived dendritic cells for a novel cancer immunotherapy

Y. Nishimura, Masatoshi Hirayama, H. Nakayama, 2022, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

A case of idiopathic common carotid artery dissection diagnosed by examining the cause of neck pain

Masatoshi Hirayama, H. Nakayama, R. Yoshida, 2020, Japanese Journal of Oral and Maxillofacial Surgery.

Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4+ T Cell Epitopes of Tumor-Associated Antigens

S. Senju, Y. Nishimura, H. Sugiyama, 2013, PloS one.

An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma

T. Fujiwara, S. Okada, Y. Kuwahara, 2022, Molecular therapy oncolytics.

Identification of CDCA1‐derived long peptides bearing both CD4+ and CD8+ T‐cell epitopes: CDCA1‐specific CD4+ T‐cell immunity in cancer patients

Yusuke Nakamura, S. Senju, Y. Nishimura, 2014, International journal of cancer.

An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs

S. Senju, Y. Nishimura, K. Kono, 2016, Oncoimmunology.

Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response

S. Senju, Y. Nishimura, K. Kono, 2015, Oncoimmunology.

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma

Tatsuro Yamamoto, Masatoshi Hirayama, H. Nakayama, 2019, International journal of molecular sciences.

The present status and future prospects of peptide-based cancer vaccines.

Y. Nishimura, Masatoshi Hirayama, 2016, International immunology.

Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR‐503‐3p‐BAK axis

R. Murakami, Y. Kuwahara, M. Fukumoto, 2021, Journal of extracellular vesicles.

The antioxidative stress regulator Nrf2 potentiates radioresistance of oral squamous cell carcinoma accompanied with metabolic modulation

R. Murakami, Y. Kuwahara, M. Fukumoto, 2022, Laboratory Investigation.

Identification of immunogenic LY6K long peptide encompassing both CD4+ and CD8+ T-cell epitopes and eliciting CD4+ T-cell immunity in patients with malignant disease

Yusuke Nakamura, S. Senju, Y. Nishimura, 2014, Oncoimmunology.

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Yusuke Nakamura, Y. Nishimura, H. Jono, 2014, Clinical Cancer Research.

Three-dimensional volumetric analysis of the efficiency of marsupialization in patients with mandibular dentigerous cysts involving impacted third molars

Kazushige Inoue, Masatoshi Hirayama, H. Nakayama, 2022, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma

Masatoshi Hirayama, H. Nakayama, M. Nagata, 2021, Biochemistry and biophysics reports.

Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method

Masatoshi Hirayama, H. Nakayama, K. Kikuchi, 2020, PloS one.

FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.

R. Murakami, Y. Kuwahara, M. Fukumoto, 2023, Laboratory investigation; a journal of technical methods and pathology.

Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients with induced immune responses and a prolonged OS.

Yusuke Nakamura, Y. Nishimura, H. Jono, 2014 .

A rare intraosseous schwannoma in the maxillary left incisor region: A case report

Masatoshi Hirayama, H. Nakayama, T. Kojima, 2020 .

Involvement of ferroptosis‐defensive xCT/GPX4 axis in radioresistance and its impacts on prognosis in oral squamous cell carcinoma

Masatoshi Hirayama, Y. Fukugawa, Junki Inoue, 2024, Oral Science International.

Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor

Yusuke Nakamura, S. Senju, Y. Nishimura, 2013, Clinical Cancer Research.

Programmed death-ligand 1-expressing extracellular vesicles are a prognostic factor in patients with oral squamous cell carcinoma treated with immune checkpoint inhibitors

R. Kariya, Masatoshi Hirayama, H. Nakayama, 2023, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.